No cancer risk from IVF drugs: study

The results appear to contradict a number of studies in recent years that suggested such treatments may increase the risk of the disease.

Safety questions have been raised about the use of clomiphene, gonadotropins and follicle stimulating hormone because they boost levels of oestradiol and progesterone, which are thought to play a role in breast, ovarian and uterine cancer.